1,157 Shares in Penumbra, Inc. (NYSE:PEN) Acquired by Gotham Asset Management LLC

Gotham Asset Management LLC acquired a new position in Penumbra, Inc. (NYSE:PEN) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 1,157 shares of the company’s stock, valued at approximately $275,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. UMB Bank n.a. lifted its position in Penumbra by 57.4% in the 4th quarter. UMB Bank n.a. now owns 192 shares of the company’s stock worth $46,000 after buying an additional 70 shares in the last quarter. Hurley Capital LLC purchased a new stake in Penumbra in the 4th quarter worth approximately $56,000. Huntington National Bank lifted its position in Penumbra by 138.7% in the 4th quarter. Huntington National Bank now owns 265 shares of the company’s stock worth $63,000 after buying an additional 154 shares in the last quarter. Mather Group LLC. lifted its position in Penumbra by 208.0% in the 4th quarter. Mather Group LLC. now owns 308 shares of the company’s stock worth $73,000 after buying an additional 208 shares in the last quarter. Finally, Jones Financial Companies Lllp lifted its position in Penumbra by 25.0% in the 4th quarter. Jones Financial Companies Lllp now owns 375 shares of the company’s stock worth $89,000 after buying an additional 75 shares in the last quarter. Institutional investors and hedge funds own 88.88% of the company’s stock.

Penumbra Price Performance

Shares of Penumbra stock opened at $281.04 on Wednesday. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.25 and a current ratio of 6.01. The firm’s 50-day simple moving average is $280.06 and its 200-day simple moving average is $264.41. Penumbra, Inc. has a twelve month low of $148.00 and a twelve month high of $310.00. The firm has a market cap of $10.88 billion, a P/E ratio of 826.59, a price-to-earnings-growth ratio of 2.83 and a beta of 0.53.

Penumbra (NYSE:PEN) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $0.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.66 by $0.17. Penumbra had a net margin of 1.17% and a return on equity of 9.74%. The firm had revenue of $324.14 million during the quarter, compared to the consensus estimate of $315.72 million. During the same period last year, the firm posted $0.41 EPS. The firm’s quarterly revenue was up 16.3% on a year-over-year basis. As a group, research analysts expect that Penumbra, Inc. will post 3.67 EPS for the current fiscal year.

Analyst Ratings Changes

PEN has been the topic of a number of recent research reports. Needham & Company LLC restated a “hold” rating on shares of Penumbra in a report on Wednesday, February 19th. Wells Fargo & Company raised their price target on shares of Penumbra from $305.00 to $315.00 and gave the company an “overweight” rating in a report on Thursday, April 24th. Royal Bank of Canada raised their price target on shares of Penumbra from $315.00 to $330.00 and gave the company an “outperform” rating in a report on Thursday, April 24th. Morgan Stanley raised their target price on shares of Penumbra from $240.00 to $260.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $330.00 target price (up from $250.00) on shares of Penumbra in a research note on Wednesday, February 19th. Three investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $302.40.

Insider Activity at Penumbra

In other Penumbra news, CFO Maggie Yuen sold 2,000 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $286.00, for a total value of $572,000.00. Following the completion of the transaction, the chief financial officer now directly owns 15,243 shares of the company’s stock, valued at approximately $4,359,498. The trade was a 11.60% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Johanna Roberts sold 600 shares of the business’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $287.43, for a total transaction of $172,458.00. Following the completion of the transaction, the executive vice president now directly owns 66,539 shares of the company’s stock, valued at approximately $19,125,304.77. This represents a 0.89% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 176,696 shares of company stock valued at $50,207,745 in the last ninety days. Insiders own 4.20% of the company’s stock.

Penumbra Profile

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.